An improved understanding of such factors has the potential to reveal targets to either enhance the persistence of activated CD4 T cells in peripheral tissues, for example in a vaccine setting, or reduce them in chronic inflammatory diseases such as RA. The gene discussed is CD4; the disease is rheumatoid arthritis.